Oversold Conditions For PTC Therapeutics (PTCT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Thursday, shares of PTC Therapeutics Inc ( PTCT) entered into oversold territory, hitting an RSI reading of 29.4, after changing hands as low as $19.92 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 43.9. A bullish investor could look at PTCT's 29.4 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of PTCT shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

PTC Therapeutics Inc 1 Year Performance Chart

Looking at the chart above, PTCT's low point in its 52 week range is $13.04 per share, with $34.65 as the 52 week high point — that compares with a last trade of $20.39.

If you liked this article you might like

Solid Biosciences Soars 41% in IPO Despite Late Disclosure of FDA Letter

Solid Biosciences Soars 41% in IPO Despite Late Disclosure of FDA Letter

Flexion Shares Continue Rise After FDA Approval -- Biotech Movers

Flexion Shares Continue Rise After FDA Approval -- Biotech Movers

No Good Stock Left Behind: Cramer's 'Mad Money' Recap (Tuesday 7/25/17)

No Good Stock Left Behind: Cramer's 'Mad Money' Recap (Tuesday 7/25/17)

Hertz Global Holdings, Honeywell, PetMed Express, Allergan: 'Mad Money' Lightning Round

Hertz Global Holdings, Honeywell, PetMed Express, Allergan: 'Mad Money' Lightning Round

Biotech Movers: Albany Molecular Shares Soar on Sale to PE Firms

Biotech Movers: Albany Molecular Shares Soar on Sale to PE Firms